StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a report released on Monday morning. The firm issued a hold rating on the software maker’s stock.
Veradigm Stock Down 1.7 %
NASDAQ:MDRX opened at $10.40 on Monday. The stock’s fifty day moving average price is $9.77 and its two-hundred day moving average price is $9.51. Veradigm has a 52-week low of $5.01 and a 52-week high of $12.66.
Institutional Trading of Veradigm
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC acquired a new position in shares of Veradigm Inc. (NASDAQ:MDRX – Free Report) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 3,974 shares of the software maker’s stock, valued at approximately $38,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Recommended Stories
- Five stocks we like better than Veradigm
- What is the NASDAQ Stock Exchange?
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- How is Compound Interest Calculated?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- High Flyers: 3 Natural Gas Stocks for March 2022
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
